News

PALO ALTO, Calif. — DECEMBER 17, 2014— The Science Exchange independent validation service announced today the first successful replication study for the Reproducibility Initiative. The Reproducibility Initiative was launched in response to revelations from the pharmaceutical industry that more than 70% of published research findings cannot be reproduced, significantly impacting their ability to develop effective new therapies to treat disease. The Reproducibility Initiative solves the reproducibility problem by identifying and rewarding high quality reproducible research through independent validation of key experimental results.


The cytoskeleton is a complex organizational nexus that provides far more than just structural support for the cell. While its name may imply a rigid and immutable structure, the cytoskeleton is actually a dynamic interconnected network of filamentous proteins interacting with hundreds of different molecular motors, cross-linkers, and cargo containing vesicles.
Independent Validation

Independent Validation

Two more antibodies for the detection of different antigens were successfully tested in Western Blot experiments. The antibodies-online antibody for the detection of beta Catenin was tested with MCF-7 cells and SK-BR-3 cells. In MCF-7 cells a clear band was visible in the correct size of beta Catenin.

Furthermore, the antibodies-online antibody ABIN98862 for the detection of human EGFR was validated in combination with MCF-7 and A549 cells. The presence of EGFR could be clearly seen in A549 cell lysates.


Your Benefits
  • Personal Customer Service
  • Order easily via shop, email, phone or fax
  • Worldwide Delivery
  • Money-Back Guarantee
back to top